R.WongS
Additional Breakthrough T1D-funded research on GLP-1 and SGLT therapies is investigating the benefits of these drugs for people with T1D, including reducing the risk of common complications of type 1 diabetes like cardiovascular disease and kidney disease
The issue is that life gets in the way and stressers come and we eat because we are bored and we eat because we're sad and we eat because it's 9:00 at night and we've had a stressful day." Drucker said GLP medications work in two ways to tell patients that they're not hungry
It will be interesting to see how these more affordable generics impact adherence rates and, subsequently, long-term cardiovascular outcomes in these populations, particularly given the challenges in managing side effects and ensuring proper patient education
It remains uncertain how these illnesses relate to lymphocytic thyroiditis, which has until now been largely identified as an organ specific disease
Why thyroid history matters for GLP-1 choice There is a second, safety-related reason we ask about your thyroid